Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 341

1.

Heterologous prime-boost with A(H5N1) pandemic influenza vaccines induces broader cross-clade antibody responses than homologous prime-boost.

Levine MZ, Holiday C, Jefferson S, Gross FL, Liu F, Li S, Friel D, Boutet P, Innis BL, Mallett CP, Tumpey TM, Stevens J, Katz JM.

NPJ Vaccines. 2019 May 29;4:22. doi: 10.1038/s41541-019-0114-8. eCollection 2019.

2.

Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons.

Gubareva LV, Mishin VP, Patel MC, Chesnokov A, Nguyen HT, De La Cruz J, Spencer S, Campbell AP, Sinner M, Reid H, Garten R, Katz JM, Fry AM, Barnes J, Wentworth DE.

Euro Surveill. 2019 Jan;24(3). doi: 10.2807/1560-7917.ES.2019.24.3.1800666.

3.

Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh.

Lewis KDC, Ortiz JR, Rahman MZ, Levine MZ, Rudenko L, Wright PF, Katz JM, Dally L, Rahman M, Isakova-Sivak I, Ilyushina NA, Matyushenko V, Fry AM, Lindstrom ST, Bresee JS, Brooks WA, Neuzil KM.

Clin Infect Dis. 2018 Nov 27. doi: 10.1093/cid/ciy1003. [Epub ahead of print]

PMID:
30481272
4.

The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children.

Brickley EB, Wright PF, Khalenkov A, Neuzil KM, Ortiz JR, Rudenko L, Levine MZ, Katz JM, Brooks WA.

Clin Infect Dis. 2018 Nov 27. doi: 10.1093/cid/ciy1004. [Epub ahead of print]

PMID:
30481269
5.

Reproducibility of the Measurement of Bulk/Tapped Density of Pharmaceutical Powders Between Pharmaceutical Laboratories.

Akseli I, Hilden J, Katz JM, Kelly RC, Kramer TT, Mao C, Osei-Yeboah F, Strong JC.

J Pharm Sci. 2019 Mar;108(3):1081-1084. doi: 10.1016/j.xphs.2018.10.009. Epub 2018 Oct 13.

PMID:
30326209
6.

Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness.

Barr IG, Donis RO, Katz JM, McCauley JW, Odagiri T, Trusheim H, Tsai TF, Wentworth DE.

NPJ Vaccines. 2018 Oct 9;3:44. doi: 10.1038/s41541-018-0079-z. eCollection 2018. Review.

7.

Occult paroxysmal atrial fibrillation in non-cryptogenic ischemic stroke.

Katz JM, Eng MS, Carrazco C, Patel AV, Jadonath R, Gribko M, Arora R, Libman RB.

J Neurol. 2018 Oct;265(10):2237-2242. doi: 10.1007/s00415-018-8982-9. Epub 2018 Jul 24.

PMID:
30043320
8.

Development of a high-throughput assay to detect antibody inhibition of low pH induced conformational changes of influenza virus hemagglutinin.

Trost JF, LeMasters EH, Liu F, Carney P, Lu X, Sugawara K, Hongo S, Stevens J, Steinhauer DA, Tumpey T, Katz JM, Levine MZ, Li ZN.

PLoS One. 2018 Jun 27;13(6):e0199683. doi: 10.1371/journal.pone.0199683. eCollection 2018.

9.

Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses After Influenza Vaccination in Adults.

Liu F, Tzeng WP, Horner L, Kamal RP, Tatum HR, Blanchard EG, Xu X, York I, Tumpey TM, Katz JM, Lu X, Levine MZ.

J Infect Dis. 2018 Oct 5;218(10):1571-1581. doi: 10.1093/infdis/jiy376.

PMID:
29931203
10.

Causes and Treatment of Acute Ischemic Stroke During Pregnancy.

Terón I, Eng MS, Katz JM.

Curr Treat Options Neurol. 2018 May 21;20(6):21. doi: 10.1007/s11940-018-0506-5. Review.

PMID:
29785465
11.

Human infection with avian influenza A(H7N2) virus-Virginia, 2002.

Terebuh P, Adija A, Edwards L, Rowe T, Jenkins S, Kleene J, Fukuda K, Katz JM, Bridges CB.

Influenza Other Respir Viruses. 2018 Jul;12(4):529-532. doi: 10.1111/irv.12546. Epub 2018 Mar 13.

12.

Kinetics of Serological Responses in Critically Ill Patients Hospitalized With 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009-2011.

Rolfes MA, Gross FL, Flannery B, Meyers AFA, Luo M, Bastien N, Fowler RA, Katz JM, Levine MZ, Kumar A, Uyeki TM; CSIS and ROSII Study Groups.

J Infect Dis. 2018 Mar 13;217(7):1078-1088. doi: 10.1093/infdis/jiy013.

13.

Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016.

Ortiz JR, Hickling J, Jones R, Donabedian A, Engelhardt OG, Katz JM, Madhi SA, Neuzil KM, Rimmelzwaan GF, Southern J, Spiro DJ, Hombach J.

Vaccine. 2018 Feb 8;36(7):932-938. doi: 10.1016/j.vaccine.2017.11.061. Epub 2017 Dec 6.

14.

Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States.

Russell KE, Bresee JS, Katz JM, Olsen SJ.

Vaccine. 2018 Jan 4;36(2):306-312. doi: 10.1016/j.vaccine.2017.10.104. Epub 2017 Dec 2.

15.

Improving Regional Stroke Systems of Care.

Eng MS, Patel AV, Libman RB, Wright P, Katz JM.

Curr Atheroscler Rep. 2017 Oct 24;19(12):52. doi: 10.1007/s11883-017-0693-7. Review.

PMID:
29063973
16.

Prevalence and Risk Factors for Paroxysmal Atrial Fibrillation and Flutter Detection after Cryptogenic Ischemic Stroke.

Carrazco C, Golyan D, Kahen M, Black K, Libman RB, Katz JM.

J Stroke Cerebrovasc Dis. 2018 Jan;27(1):203-209. doi: 10.1016/j.jstrokecerebrovasdis.2017.08.022. Epub 2017 Oct 9.

PMID:
29032886
17.

A robust quantitative near infrared modeling approach for blend monitoring.

Mohan S, Momose W, Katz JM, Hossain MN, Velez N, Drennen JK 3rd, Anderson CA.

J Pharm Biomed Anal. 2018 Jan 30;148:51-57. doi: 10.1016/j.jpba.2017.09.011. Epub 2017 Sep 9.

PMID:
28957719
18.

Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants.

Liu F, Veguilla V, Gross FL, Gillis E, Rowe T, Xu X, Tumpey TM, Katz JM, Levine MZ, Lu X.

J Infect Dis. 2017 Sep 15;216(suppl_4):S539-S547. doi: 10.1093/infdis/jix093.

19.

Mild Respiratory Illness Among Young Children Caused by Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in Dhaka, Bangladesh, 2011.

Chakraborty A, Rahman M, Hossain MJ, Khan SU, Haider MS, Sultana R, Ali Rimi N, Islam MS, Haider N, Islam A, Sultana Shanta I, Sultana T, Al Mamun A, Homaira N, Goswami D, Nahar K, Alamgir ASM, Rahman M, Mahbuba Jamil K, Azziz-Baumgartner E, Simpson N, Shu B, Lindstrom S, Gerloff N, Davis CT, Katz JM, Mikolon A, Uyeki TM, Luby SP, Sturm-Ramirez K.

J Infect Dis. 2017 Sep 15;216(suppl_4):S520-S528. doi: 10.1093/infdis/jix019.

PMID:
28934459
20.

Cross-Reactive Antibody Responses to Novel H5Nx Influenza Viruses Following Homologous and Heterologous Prime-Boost Vaccination with a Prepandemic Stockpiled A(H5N1) Vaccine in Humans.

Levine MZ, Holiday C, Liu F, Jefferson S, Gillis E, Bellamy AR, Tumpey T, Katz JM.

J Infect Dis. 2017 Sep 15;216(suppl_4):S555-S559. doi: 10.1093/infdis/jix001.

21.

Intracranial Bypass of Posterior Inferior Cerebellar Artery Aneurysms: Indications, Technical Aspects, and Clinical Outcomes.

Bonda DJ, Labib M, Katz JM, Ortiz RA, Chalif D, Setton A, Langer DJ, Dehdashti AR.

Oper Neurosurg (Hagerstown). 2017 Oct 1;13(5):586-595. doi: 10.1093/ons/opx064. Erratum in: Oper Neurosurg (Hagerstown). 2017 Dec 1;13(6):766.

PMID:
28922886
22.

Prediction of Air Entrapment in Tableting: An Approximate Solution.

Zavaliangos A, Katz JM, Daurio D, Johnson M, Pirjanian A, Alvarez-Nunez F.

J Pharm Sci. 2017 Dec;106(12):3604-3612. doi: 10.1016/j.xphs.2017.09.001. Epub 2017 Sep 15.

PMID:
28919383
23.

Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic - China, October 1, 2016-August 7, 2017.

Kile JC, Ren R, Liu L, Greene CM, Roguski K, Iuliano AD, Jang Y, Jones J, Thor S, Song Y, Zhou S, Trock SC, Dugan V, Wentworth DE, Levine MZ, Uyeki TM, Katz JM, Jernigan DB, Olsen SJ, Fry AM, Azziz-Baumgartner E, Davis CT.

MMWR Morb Mortal Wkly Rep. 2017 Sep 8;66(35):928-932. doi: 10.15585/mmwr.mm6635a2. Erratum in: MMWR Morb Mortal Wkly Rep. 2017 Oct 13;66(40):1084.

24.

Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.

Belser JA, Johnson A, Pulit-Penaloza JA, Pappas C, Pearce MB, Tzeng WP, Hossain MJ, Ridenour C, Wang L, Chen LM, Wentworth DE, Katz JM, Maines TR, Tumpey TM.

Virology. 2017 Nov;511:135-141. doi: 10.1016/j.virol.2017.08.024. Epub 2017 Aug 29.

25.

Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.

Nasreen S, Rahman M, Hancock K, Katz JM, Goswami D, Sturm-Ramirez K, Holiday C, Jefferson S, Branch A, Wang D, Veguilla V, Widdowson MA, Fry AM, Brooks WA.

Influenza Other Respir Viruses. 2017 Sep;11(5):394-398. doi: 10.1111/irv.12462. Epub 2017 Jul 26.

26.

Novel influenza A viruses and pandemic threats.

Uyeki TM, Katz JM, Jernigan DB.

Lancet. 2017 Jun 3;389(10085):2172-2174. doi: 10.1016/S0140-6736(17)31274-6. No abstract available.

PMID:
28589883
27.

Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.

Sun X, Belser JA, Pulit-Penaloza JA, Creager HM, Guo Z, Jefferson SN, Liu F, York IA, Stevens J, Maines TR, Jernigan DB, Katz JM, Levine MZ, Tumpey TM.

Virology. 2017 Aug;508:164-169. doi: 10.1016/j.virol.2017.05.010. Epub 2017 May 26.

28.

Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.

Cao W, Kim JH, Reber AJ, Hoelscher M, Belser JA, Lu X, Katz JM, Gangappa S, Plante M, Burt DS, Sambhara S.

Vaccine. 2017 Jun 5;35(25):3318-3325. doi: 10.1016/j.vaccine.2017.05.004. Epub 2017 May 9.

PMID:
28499553
29.

Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic - China, October 2016-February 2017.

Iuliano AD, Jang Y, Jones J, Davis CT, Wentworth DE, Uyeki TM, Roguski K, Thompson MG, Gubareva L, Fry AM, Burns E, Trock S, Zhou S, Katz JM, Jernigan DB.

MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):254-255. doi: 10.15585/mmwr.mm6609e2.

30.

Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.

Li ZN, Trost JF, Weber KM, LeMasters EH, Nasreen S, Esfandiari J, Gunasekera AH, McCausland M, Sturm-Ramirez K, Wrammert J, Gregory S, Veguilla V, Stevens J, Miller JD, Katz JM, Levine MZ.

Influenza Other Respir Viruses. 2017 May;11(3):289-297. doi: 10.1111/irv.12449. Epub 2017 Apr 5.

31.

Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responses.

Li ZN, Weber KM, Limmer RA, Horne BJ, Stevens J, Schwerzmann J, Wrammert J, McCausland M, Phipps AJ, Hancock K, Jernigan DB, Levine M, Katz JM, Miller JD.

J Virol Methods. 2017 May;243:61-67. doi: 10.1016/j.jviromet.2017.01.008. Epub 2017 Jan 17.

PMID:
28108183
32.

Full Out-of-Die Compressibility and Compactibility Profiles From Two Tablets.

Katz JM, Buckner IS.

J Pharm Sci. 2017 Mar;106(3):843-849. doi: 10.1016/j.xphs.2016.11.005. Epub 2016 Dec 6.

PMID:
27938894
33.

A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants.

Mishin VP, Baranovich T, Garten R, Chesnokov A, Abd Elal AI, Adamczyk M, LaPlante J, St George K, Fry AM, Barnes J, Chester SC, Xu X, Katz JM, Wentworth DE, Gubareva LV.

J Clin Microbiol. 2016 Dec 28;55(1):145-154. doi: 10.1128/JCM.01840-16. Print 2017 Jan.

34.

Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains.

Reber AJ, Kim JH, Coleman LA, Spencer SM, Chung JR, Chen J, Gargiullo P, Sundaram ME, Belongia EA, Shay DK, Katz JM, Sambhara S.

J Infect Dis. 2016 Nov 15;214(10):1477-1486. Epub 2016 Aug 28.

35.

Improving Transfer Times for Acute Ischemic Stroke Patients to a Comprehensive Stroke Center.

Kodankandath TV, Wright P, Power PM, De Geronimo M, Libman RB, Kwiatkowski T, Katz JM.

J Stroke Cerebrovasc Dis. 2017 Jan;26(1):192-195. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.008. Epub 2016 Oct 12.

PMID:
27743926
36.

Selection of antigenically advanced variants of seasonal influenza viruses.

Li C, Hatta M, Burke DF, Ping J, Zhang Y, Ozawa M, Taft AS, Das SC, Hanson AP, Song J, Imai M, Wilker PR, Watanabe T, Watanabe S, Ito M, Iwatsuki-Horimoto K, Russell CA, James SL, Skepner E, Maher EA, Neumann G, Klimov AI, Kelso A, McCauley J, Wang D, Shu Y, Odagiri T, Tashiro M, Xu X, Wentworth DE, Katz JM, Cox NJ, Smith DJ, Kawaoka Y.

Nat Microbiol. 2016 May 23;1(6):16058. doi: 10.1038/nmicrobiol.2016.58.

37.

Thrombolysis for Ischemic Stroke during Pregnancy: A Case Report and Review of the Literature.

Tversky S, Libman RB, Reppucci ML, Tufano AM, Katz JM.

J Stroke Cerebrovasc Dis. 2016 Oct;25(10):e167-70. doi: 10.1016/j.jstrokecerebrovasdis.2016.06.023. Epub 2016 Aug 11. Review.

PMID:
27523596
38.

Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age.

Arora R, Salamon E, Katz JM, Cox M, Saver JL, Bhatt DL, Fonarow GC, Peterson ED, Smith EE, Schwamm LH, Xian Y, Libman RB.

Stroke. 2016 Sep;47(9):2347-54. doi: 10.1161/STROKEAHA.116.012241. Epub 2016 Aug 4.

PMID:
27491734
39.

CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.

Horby PW, Laurie KL, Cowling BJ, Engelhardt OG, Sturm-Ramirez K, Sanchez JL, Katz JM, Uyeki TM, Wood J, Van Kerkhove MD; CONSISE Steering Committee.

Influenza Other Respir Viruses. 2017 Jan;11(1):2-14. doi: 10.1111/irv.12411. Epub 2016 Aug 9.

40.

Bilateral Vein of Trolard Thrombosis.

Mishra S, Patel AV, Katz JM, Setton A, Libman RB.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):e120-2. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.029. Epub 2016 May 24.

PMID:
27234922
41.

Poor Hypertension Control and Longer Transport Times Are Associated with Worse Outcome in Drip-and-Ship Stroke Patients.

Kodankandath TV, Shaji J, Kohn N, Arora R, Salamon E, Libman RB, Katz JM.

J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1887-90. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.013. Epub 2016 May 6.

PMID:
27160383
42.

An oil-in-water nanoemulsion enhances immunogenicity of H5N1 vaccine in mice.

Cao W, Davis WG, Kim JH, De La Cruz JA, Taylor A, Hendrickson GR, Kumar A, Ranjan P, Lyon LA, Katz JM, Gangappa S, Sambhara S.

Nanomedicine. 2016 Oct;12(7):1909-1917. doi: 10.1016/j.nano.2016.04.005. Epub 2016 Apr 23.

43.

A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.

Veguilla V, López-Gatell H, López-Martínez I, Aparicio-Antonio R, Barrera-Badillo G, Rojo-Medina J, Gross FL, Jefferson SN, Katz JM, Hernández-Ávila M, Alpuche-Aranda CM.

PLoS One. 2016 Mar 22;11(3):e0150428. doi: 10.1371/journal.pone.0150428. eCollection 2016.

44.

A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.

Liu F, Sun X, Fairman J, Lewis DB, Katz JM, Levine M, Tumpey TM, Lu X.

Virology. 2016 May;492:197-203. doi: 10.1016/j.virol.2016.02.024. Epub 2016 Mar 21.

45.

Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.

Zhong W, Gross FL, Holiday C, Jefferson SN, Bai Y, Liu F, Katz JM, Levine MZ.

Viral Immunol. 2016 May;29(4):259-62. doi: 10.1089/vim.2016.0003. Epub 2016 Mar 7.

PMID:
26950058
46.

NADPH Oxidase 1 Is Associated with Altered Host Survival and T Cell Phenotypes after Influenza A Virus Infection in Mice.

Hofstetter AR, De La Cruz JA, Cao W, Patel J, Belser JA, McCoy J, Liepkalns JS, Amoah S, Cheng G, Ranjan P, Diebold BA, Shieh WJ, Zaki S, Katz JM, Sambhara S, Lambeth JD, Gangappa S.

PLoS One. 2016 Feb 24;11(2):e0149864. doi: 10.1371/journal.pone.0149864. eCollection 2016.

47.

Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.

Thompson MG, Naleway A, Fry AM, Ball S, Spencer SM, Reynolds S, Bozeman S, Levine M, Katz JM, Gaglani M.

Vaccine. 2016 Feb 10;34(7):981-8. doi: 10.1016/j.vaccine.2015.10.119.

48.

Catastrophic Intracranial Hemorrhages after IV tPA in a Patient with Insidious Onset of Fever and Back Pain.

Tversky S, Libman RB, Schloss ER, Arora R, Patel AV, Salamon EJ, Wright P, Katz JM.

J Stroke Cerebrovasc Dis. 2016 May;25(5):e69-e70. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.004. Epub 2016 Jan 21.

PMID:
26806798
49.

A highly immunogenic vaccine against A/H7N9 influenza virus.

Cao W, Liepkalns JS, Hassan AO, Kamal RP, Hofstetter AR, Amoah S, Kim JH, Reber AJ, Stevens J, Katz JM, Gangappa S, York IA, Mittal SK, Sambhara S.

Vaccine. 2016 Feb 3;34(6):744-9. doi: 10.1016/j.vaccine.2015.12.062. Epub 2016 Jan 4.

50.

Human Heat shock protein 40 (Hsp40/DnaJB1) promotes influenza A virus replication by assisting nuclear import of viral ribonucleoproteins.

Batra J, Tripathi S, Kumar A, Katz JM, Cox NJ, Lal RB, Sambhara S, Lal SK.

Sci Rep. 2016 Jan 11;6:19063. doi: 10.1038/srep19063.

Supplemental Content

Support Center